Document is current
Any future updates will be listed below
-
Authors
Lodise, Thomas P.
Nguyen, Sean T.
Margiotta, Caroline
Cai, Bin
-
Funding
Funding for this research was provided by:
Shionogi Inc.
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 4 March 2025
First Online: 17 April 2025
Declarations
:
: Not applicable. This study is conducted using an anonymous, commercially available secondary healthcare database called PINC AI™ Database that meets the US Health Insurance Portability and Accountability Act requirement. This retrospective study required neither ethics committee or institutional review board approval nor informed patient consent. All information in the PINC AI™ Database is de-identified, making it fully compliant with the US Health Insurance Portability and Accountability Act (1996), thus, exempting it from ethics committee or institutional review board approval per US 45 Code of Federal Regulations Part 46, human participant protection regulations, and Protections of Human Subjects.
: Not applicable.
: TL has received consultancy fee from AbbVie, Cidara, Ferring, Genentech, GlaxoSmithKline, ICPD, Melinta, Merck, Paratek, Roche, Seres, Shionogi, and VenatoRx; research grants from Merck and Wockhardt; participated in speakers’ bureau for Ferring and Shionogi. BC, STN are employees of Shionogi. CM has no conflict of interest.
